Department of Otolaryngology, Khonkaen University
Muang, Khonkaen, 40002, Thailand
NCT Number: NCT02763241
The investigators proposed that the Cleanoze® is superior to the traditional nasal saline irrigation in term of the ease of use which will resulting in a better quality of life of the participants. This study will compared the efficacy, adverse reactions, complications and ease of use of Cleanoze® comparing with normal saline solution
Looking for future studies?
Notify Me5 year and older
All sexes
Interventional
Phase 3
Muang, Khonkaen, 40002, Thailand
Cleanoze® consists of a powder made up of Sodium chloride and Sodium Bicarbonate. This powder when dissolved in 250 ml of water is closely resembles the content of a body fluid which normally baths the outside of the cells of the body. This fluid is isotonic solution.
The nasal saline irrigation is the common procedure for upper respiratory tract infection patients including chronic rhinitis. The physician usually order the normal saline with appropriate medication e.g. anti-histamines, nasal steroids and anti-biotics to treat this condition.
The investigators proposed that the Cleanoze® is superior to the traditional nasal saline irrigation in term of the ease of use which will resulting in a better quality of life of the participants. This study will compared the efficacy, adverse reactions, complications and ease of use of Cleanoze® comparing with normal saline solution.
Study Population: Any patients with chronic rhinitis (e.g. allergic rhinitis, vasomotor rhinitis) will be randomized to receive the study or control medication. The investigators will include the children 5 years and above which able to doing the lavage under the parents assistant or by them self.
Study Design: Phase III randomized controlled trial
Sample Size: Estimate from pilot study, the 71 patients per arm was estimated (142 participants totally).
Study Duration:
Primary Objective: To compare the satisfaction of the patients using Cleanoze® versus conventional device
Secondary Objective(s):
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cleanoze® consists of a powder made up of Sodium chloride and Sodium Bicarbonate. This powder when dissolved in 250 ml of water is closely resembles the content of a body fluid which normally baths the outside of the cells of the body. This fluid is isotonic solution.
Nasal irrigation using 250 ml normal saline pushing into the nostril by 20 ml syringe
Time frame: 1 month
This score will be evaluated at the end of 1 month using using the satisfaction questionaire
Time frame: 1 month
The adherence will be evaluated by the diary that the investigator given to the participants
Time frame: 1 month
The durability will be evaluated by inspecting the device at the end of 1 month period
Time frame: 1 month
The symptoms score will be evaluated using the one-question VAS scale
Time frame: 1 month
The SNOT-22 score will be evaluated by using SNOT-22 questionnaire
Time frame: 1 month
The adverse events will be recorded in the case record form at follow-up time
Khon Kaen University
Other
Phase III Randomized Open-label Clinical Trial Comparing Cleanoze® Irrigation Device With Powder Preparation Versus Conventional Irrigation Method for Chronic Rhinitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06448585
Allergic Rhinoconjunctivitis, Controlled Asthma
Don Benito, Badajoz, Spain
View Trial DetailsNCT07140250
Airway Obstruction, Infections
La Jolla, California, United States
View Trial DetailsNCT06812676
Agnosia, Deviated Nasal Septum - Congenital
Riyadh, Saudi Arabia
View Trial DetailsNCT04012216
Infections, Nose Diseases
Montpellier, Hérault, France
View Trial Details